Activation of the GCN2/ATF4 pathway in cancer cells promotes tumorigenesis, while targeted deletion of ATF4 and/or GCN2 resulted in apoptosis and tumor regression (Ye et al., 2010). This evidence concerns the gene EIF2AK4 and cancer.